LFCR Company Profile and Key Details
Lifecore Biomedical, Inc.
LFCR Stock Price Chart
Stock Price Today
Lifecore Biomedical, Inc. (LFCR) stock declined over -1.98%, trading at $6.43 on NASDAQ, down from the previous close of $6.56. The stock opened at $6.55, fluctuating between $6.37 and $6.58 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.
Company Information
| Employees | 524 |
| Beta | 0.94 |
| Sales or Revenue | $128.26M |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | May |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions
Lifecore Biomedical, Inc. (NASDAQ: LFCR) stock price is $6.43 in the last trading session. During the trading session, LFCR stock reached the peak price of $6.58 while $6.37 was the lowest point it dropped to. The percentage change in LFCR stock occurred in the recent session was -1.98% while the dollar amount for the price change in LFCR stock was -$0.13.
The NASDAQ listed LFCR is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Lifecore Biomedical, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Jackie Q. Klecker
Executive Vice President & GM
Dr. Albert D. Bolles Ph.D.
Pres of Curation Foods, Inc.
Mr. Parker K. Javid
Vice President
Mr. Aaron Perlitsh
Director of Internal Audit & Chief Compliance Officer
Dr. Kipling Thacker Ph.D.
Vice President & Chief Scientist
Mr. John D. Morberg
Chief Financial Officer & Sec.
Mr. James G. Hall
Chief Executive Officer, Pres & Director
Ms. Kara Morley
Senior Vice President of HR
Mr. Matt Augustson
Senior Vice President of Information Technology
Mr. Steve W. Laninga
Vice President of Operations
Mr. Darren M. Hieber
Senior Vice President of Corporation Devel. & Partnerships
LFCR's closing price is 74.73% higher than its 52-week low of $3.68 where as its distance from 52-week high of $8.90 is -27.75%.
Number of LFCR employees currently stands at 524.
Official Website of LFCR is: https://www.lifecore.com
LFCR could be contacted at phone 952 368 4300 and can also be accessed through its website. LFCR operates from 3515 Lyman Boulevard, Chaska, MN 55318, United States.
LFCR stock volume for the day was 246.4K shares. The average number of LFCR shares traded daily for last 3 months was 250.1K.
The market value of LFCR currently stands at $238.07M with its latest stock price at $6.43 and 37.03M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com